Negative predictive value of multiparametric MRI for prostate cancer detection: Outcome of 5-year follow-up in men with negative findings on initial MRI studies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vilanova, 2001, The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients, Eur Radiol, 11, 229, 10.1007/s003300000616
Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702
Cooner, 1990, Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen, J Urol, 143, 1146, 10.1016/S0022-5347(17)40211-4
Rabbani, 1998, Incidence and clinical significance of false-negative sextant prostate biopsies, J Urol, 159, 1247, 10.1016/S0022-5347(01)63574-2
Ploussard, 2010, Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance – does the risk of misclassification vary according to biopsy criteria?, J Urol, 183, 539, 10.1016/j.juro.2009.10.009
Lilja, 2008, Prostate-specific antigen and prostate cancer: prediction, detection and monitoring, Nat Rev Cancer, 8, 268, 10.1038/nrc2351
Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084
Turkbey, 2011, Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds, J Urol, 186, 1818, 10.1016/j.juro.2011.07.013
Lawrentschuk, 2009, The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels, BJU Int, 103, 730, 10.1111/j.1464-410X.2008.08205.x
Kirkham, 2006, How good is MRI at detecting and characterising cancer within the prostate?, Eur Urol, 50, 1163, 10.1016/j.eururo.2006.06.025
Villeirs, 2011, Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients, Eur J Radiol, 77, 340, 10.1016/j.ejrad.2009.08.007
Kumar, 2008, Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10ng/ml: a follow-up study, Urology, 72, 859, 10.1016/j.urology.2008.01.014
Yerram, 2012, Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer, BJU Int, 110, E783, 10.1111/j.1464-410X.2012.11646.x
Akin, 2006, Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging, Radiology, 239, 784, 10.1148/radiol.2392050949
Haider, 2007, Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer, Am J Roentgenol, 189, 323, 10.2214/AJR.07.2211
Kikuchi, 2004, Is tumor volume an independent prognostic factor in clinically localized prostate cancer?, J Urol, 172, 508, 10.1097/01.ju.0000130481.04082.1a
Ohori, 1994, The pathological features and prognosis of prostate cancer detectable with current diagnostic tests, J Urol, 152, 1714, 10.1016/S0022-5347(17)32369-8
Hosseinzadeh, 2004, Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue, J Magn Reson Imaging, 20, 654, 10.1002/jmri.20159
Zakian, 2005, Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy, Radiology, 234, 804, 10.1148/radiol.2343040363
Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036
Shimizu, 2009, Prostate cancer detection: the value of performing an MRI before a biopsy, Acta Radiol, 50, 1080, 10.3109/02841850903216718
Vargas, 2012, Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study, Radiology, 265, 478, 10.1148/radiol.12120041
Beyersdorff, 2002, Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging, Radiology, 224, 701, 10.1148/radiol.2243011553
Perrotti, 1999, Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostatic biopsy: a pilot study, J Urol, 162, 1314, 10.1016/S0022-5347(05)68275-4
Yuen, 2004, Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy, J Urol, 171, 1482, 10.1097/01.ju.0000118380.90871.ef
Scheidler, 2012, Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment, Rofo, 184, 130, 10.1055/s-0031-1281974
Wang, 2008, Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy, Radiology, 246, 168, 10.1148/radiol.2461070057
Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy – prospective multicenter study, Radiology, 268, 461, 10.1148/radiol.13121501
Rastinehad, 2011, D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging, J Urol, 185, 815, 10.1016/j.juro.2010.10.076